Myopia Progression Control Using Atropine 0.05% After Pediatric Cataract Surgery And Intraocular Lens Implantation Surgery

Starting soon · Not applicable

Conditions studied: Pediatric Cataract, IOL Implantation, Myopia Progression

In brief

Myopic shift remains a debilitating and unpredictable adverse event following pediatric cataract surgery. While research exploring peripheral myopic defocus for post-cataract surgery myopia prevention shows promising results, the use of multifocal intra-ocular lenses (IOLs) cannot be used liberally in countries with high disease burden and challenged economies due to high price and decreased availability. To date there are no studies evaluating the use of topical atropine for the management of myopic shift following pediatric cataract surgery. The investigators aim to explore the use of 0.05% topical atropine in the prevention and management of myopic shift following pediatric cataract surgery.

Key facts

Study ID

NCT07364370

Run by

Cairo University

People needed

50

Starts

2026-02-01

Expected to finish

2027-12-01

Last updated by the study team

2026-01-23

Who can join

Age: 1 and older, up to 7. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children after IOL implantation (primary or secondary)
• Age 1-7 years

You may not qualify if…

• Eyes with post-operative media opacity hindering adequate assessment of refraction
• Eyes with complicated surgeries (e.g. vitreous loss, dropped lens matter requiring PPV, retinal detachment, etc)
• Retinal pathologies
• Glaucoma (congenital or secondary to surgery)
• Anterior or posterior segment anomalies

Where it is running

• Cairo University — Cairo, Egypt

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.